Objective.—To determine whether extended‐cycle dosing of an ultralow dose vaginal ring
contraceptive decreases frequency of migraine aura and prevents menstrual related …

Objective.—This paper will review the extensive array of hormonal contraceptives. It will
examine the benefits and risks associated with them–particularly with regard to stroke risk …

Abstract Purpose of Review There is an overlap in the populations of patients who suffer
from migraine headaches and patients who seek contraception. The purpose of this review …

Unnecessary confusion still surrounds the use of combined hormonal contraceptives
(CHCs) in the setting of migraine with aura (MwA). Clearing this confusion is a key issue for …

Migraine is highly prevalent in women, particularly in the reproductive years when
contraception may be needed. Preventive strategies are known to be underutilized for …

Background Combined hormonal contraception might worsen migraine in sensitive women,
especially during the free-hormone interval, and raise concerns about the vascular risk. The …

Combined hormonal contraceptives are contraindicated in women who have migraine with
aura, in whom these drugs can increase the risk of ischemic stroke. However, this …

Most women have used at least 1 method of contraception during their reproductive years,
with the majority favoring combined oral contraceptives. Women are often concerned about …

At least 18% of women suffers from migraine. Clinically, there are two main forms of
migraine: migraine with aura (MA) and migraine without aura (MO) and more than 50% of …

BACKGROUND: Migraine with aura (MA) is a contraindication to the use of combined oral
contraceptives (COCs) because of the increased risk of ischemic stroke. Progestogen-only …